PREVALENCE OF METAMORPHOPSIA IN PATIENTS WITH VITREOMACULAR TRACTION, WITH OR WITHOUT MACULAR HOLE, AND ITS IMPACT ON QUALITY OF LIFE- THE MEMO STUDY
Author(s)
Brazier J1, Hirneiß C2, Tangelder M3, Lescrauwaet B4, Patel P5
1University of Sheffield, Sheffield, UK, 2Ludwig Maximilians University München, München, Germany, 3ThromboGenics NV, Leuven, Belgium, 4Xintera Ltd., London, UK, 5NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK
OBJECTIVES: Metamorphopsia (MM) is a common symptom of visual function disturbance in macular disorders. MM is disabling to the patient and may cause deterioration of quality of life (QoL). There is no evidence on the prevalence of MM and its impact on QoL in patients with VMT. METHODS: A multi-centre, observational, cross-sectional study in the UK, prospectively enrolled patients with a recent diagnosis of VMT, with or without MH. Data were collected on demographics, medical history, ocular comorbidities and interventions, retinal and OCT findings, and ocular diagnosis of the affected and fellow eyes. Patients completed the VFQ-25, HUI3, and EQ-5D questionnaires. The presence and severity of MM was self-reported using a validated metamorphopsia questionnaire. The impact of MM on QoL was adjusted for relevant demographic and clinical covariates using linear regression models. RESULTS:
Conference/Value in Health Info
2016-05, ISPOR 2016, Washington DC, USA
Value in Health, Vol. 19, No. 3 (May 2016)
Code
PSS25
Topic
Patient-Centered Research
Topic Subcategory
Health State Utilities, Patient-reported Outcomes & Quality of Life Outcomes
Disease
Sensory System Disorders